NCT06528093
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06528093
Title A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
HealthONE Denver Colorado 80218 United States Details
Yale Cancer Center New Haven Connecticut 06510 United States Details
Florida Cancer Specialists-Sarasota-61670 Sarasota Florida 34232 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Cliniques Universitaires Saint-Luc Brussels 1200 Belgium Details
UZ Leuven Leuven 3000 Belgium Details
CTR Leon Berard Lyon 69373 France Details
CTR Eugène Marquis Rennes 35042 France Details
INS Gustave Roussy Villejuif 94805 France Details
Universitätsklinikum Hamburg, Eppendorf Hamburg 20246 Germany Details
Universitätsklinikum Heidelberg Heidelberg 69120 Germany Details
Klinikum der Universität München AÖR München 81377 Germany Details
National Cancer Center Hospital East Chiba, Kashiwa 277-8577 Japan Details
National Cancer Center Hospital Tokyo, Chuo-ku 104-0045 Japan Details
Hospital Clínic de Barcelona Barcelona 08036 Spain Details
Hospital Universitario Ramon Y Cajal Madrid 28034 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field